Bogue Zachary

CIK 00018361573 companiesPALO ALTO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001836157

Recent Transactions

34 trades

Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-07-03+1,440→ 9,378 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-04-03+1,542→ 7,938 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2023-01-03+1,407→ 6,396 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-10-03+977→ 4,989 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-30$9.64/sh+10,000→ 3,212,107 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-18$11.64/sh+10,000→ 3,202,107 total
Purchase
Embark Technology, Inc.
Class A Common Stock
2022-08-16$0.84/sh+122,000→ 3,192,107 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-07-01+1,260→ 4,012 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-04-01+1,382→ 2,752 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2022-01-03+589→ 1,370 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-10-01+295→ 781 total
Award
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-07-01+295→ 295 total
Other
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-18+73,892→ 73,892 total
Other
AbCellera Biologics Inc.$ABCL
Common Shares
2021-06-18−5,000,000→ 24,105,761 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series D Preferred Stock
2021-04-20−3,726,963→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−3,726,963→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−5,941,120→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series A Preferred Stock
2021-04-20−3,771,996→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series B Preferred Stock
2021-04-20−3,220,788→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20−3,951,141→ 0 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-04-20+3,951,141→ 3,951,141 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+5,941,120→ 5,941,120 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-04-20+5,941,120→ 5,941,120 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+3,951,141→ 3,951,141 total
Other
RECURSION PHARMACEUTICALS, INC.$RXRX
Class A Common Stock
2021-04-20+3,726,963→ 3,726,963 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series C Preferred Stock
2021-04-20−1,095,529→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series C Preferred Stock
2021-04-20−730,353→ 0 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Common Stock
2021-04-20+3,726,963→ 3,726,963 total
Conversion
RECURSION PHARMACEUTICALS, INC.$RXRX
Series B Preferred Stock
2021-04-20−1,073,595→ 0 total
Conversion
AbCellera Biologics Inc.$ABCL
Convertible Note
2020-12-15→ 0 total
Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2020-12-15+29,411→ 29,105,761 total
Conversion
AbCellera Biologics Inc.$ABCL
Series A2 Preferred Shares
2020-12-15−802,371→ 0 total
Conversion
AbCellera Biologics Inc.$ABCL
Common Shares
2020-12-15+29,076,350→ 29,076,350 total
Conversion
AbCellera Biologics Inc.$ABCL
Series A1 Preferred Shares
2020-12-15−2,105,264→ 0 total

Companies

Recent Filings

Address

270 UNIVERSITY AVENUE

PALO ALTO, CA, 94301

View on SEC.gov